Nasdaq: OBIO
Orchestra BioMed Holdings insiders
The officers, directors and 10% owners of Orchestra BioMed Holdings, Inc. who hold the most stock, valued at the live OBIO price.
$7.00
OBIO today −$460K (−6.17%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 5
- Their OBIO stock
- $63.7M
- Market value
- $551M
- Held by ranked insiders
- 11.6%
Insiders by value of OBIO holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Medtronic plc | 10% owner | 5,868,916 | $41.1M | 7.46% | Corporate |
| 2 | David P. Hochman | See Remarks | 1,943,435 | $13.6M | 2.47% | 6958th |
| 3 | Darren Sherman | See Remarks | 1,106,402 | $7.7M | 1.41% | 10613th |
| 4 | Jason Aryeh | Director | 118,118 | $827K | 0.15% | 3496th |
| 5 | Pamela Ann Connealy | Director | 66,038 | $462K | <0.1% | 12452nd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Orchestra BioMed Holdings; see each profile for the filing.